We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTL.WS
2026
CALL
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$1.86M ﹤0.01%
591,423
-58,007
-9% -$38.6K
OTTR icon
2027
Otter Tail
OTTR
$3.96B
$1.86M ﹤0.01%
+27,648
New +$1.76M
EMB icon
2028
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$1.85M ﹤0.01%
21,700
-123,700
-85% -$11.2M
RNST icon
2029
Renasant Corp
RNST
$3.92B
$1.85M ﹤0.01%
64,261
-30,173
-32% -$923K
SP
2030
DELISTED
SP Plus Corporation
SP
$1.85M ﹤0.01%
+60,185
New +$1.82M
RDBXW
2031
CALL
DELISTED
Redbox Entertainment Inc. Warrant
RDBXW
$1.85M ﹤0.01%
250,000
-19,000
-7% -$10.1K
SRTAW
2032
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$1.85M ﹤0.01%
414,666
TLS icon
2033
Telos
TLS
$321M
$1.83M ﹤0.01%
+226,927
New +$1.96M
LLAP.WS
2034
CALL
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$1.83M ﹤0.01%
399,996
FVRR icon
2035
Fiverr
FVRR
$315M
$1.83M ﹤0.01%
53,129
-77,745
-59% -$3.7M
TROX icon
2036
Tronox
TROX
$1.02B
$1.82M ﹤0.01%
108,665
-414,880
-79% -$7.51M
CANO.WS
2037
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$1.82M ﹤0.01%
416,313
+71,521
+21% +$74.1K
STRY.WS
2038
CALL
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
$1.82M ﹤0.01%
441,824
-5,916
-1% -$6.79K
LOPE icon
2039
Grand Canyon Education
LOPE
$3.76B
$1.82M ﹤0.01%
+19,300
New +$1.8M
NOAH
2040
Noah Holdings
NOAH
$591M
$1.81M ﹤0.01%
+89,764
New +$1.67M
MHO icon
2041
M/I Homes
MHO
$3.85B
$1.81M ﹤0.01%
45,763
+13,861
+43% +$602K
RNWWW
2042
CALL
ReNew Energy Global PLC Warrant
RNWWW
$18.5K
$1.81M ﹤0.01%
280,000
+55,551
+25% +$82K
CAMT icon
2043
Camtek
CAMT
$7.67B
$1.81M ﹤0.01%
72,664
-578
-0.8% -$16.5K
QTWO icon
2044
Q2 Holdings
QTWO
$3.95B
$1.81M ﹤0.01%
46,819
+42,598
+1,009% +$2.07M
VGII.WS
2045
CALL
DELISTED
Virgin Group Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one Class
VGII.WS
$1.81M ﹤0.01%
390,000
SES.WS icon
2046
CALL
SES AI Corp Warrants
SES.WS
$5.87M
$1.8M ﹤0.01%
460,000
SNOW icon
2047
Snowflake
SNOW
$116B
$1.79M ﹤0.01%
12,900
-313,309
-96% -$49.6M
YELL
2048
DELISTED
Yellow Corporation Common Stock
YELL
$1.79M ﹤0.01%
612,468
+593,021
+3,049% +$2.41M
TGAAW
2049
CALL
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$1.79M ﹤0.01%
180,264
CRDO icon
2050
Credo Technology Group
CRDO
$46.2B
$1.78M ﹤0.01%
152,902
+128,149
+518% +$1.49M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.